Min Cui – Trademark Portfolio

Entity Type: 01

Min Cui owns a portfolio of 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as LUFALT, AIPTOSY, and IDENTIY. Of these, 3 are registered. The portfolio spans 4 Nice Classification classes, led by Class 25 (Clothing) and Class 18 (Leather Goods). Headquartered in Shulan, Jilin.

The Fourth Community of Nonglin Vill

Qili Township

Shulan, Jilin 132600 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LUFALT
LUFALT
Registered 2021
AIPTOSY
AIPTOSY
Registered 2021
IDENTIY
IDENTIY
Registered 2021
CAYISU
CAYISU
Abandoned 2020

Trademark Classifications

Min Cui's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

23
Yarns & Threads (1 filing)

Yarns and threads, for textile use

Frequently Asked Questions

How many trademarks does Min Cui have?

Min Cui has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does Min Cui file in?

Min Cui files trademarks across 4 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 18 (Leather Goods), Class 12 (Vehicles), Class 23 (Yarns & Threads). Class 25 covers clothing, footwear, headgear.

What are Min Cui's most well-known trademarks?

Min Cui's registered trademark portfolio includes well-known marks such as LUFALT, AIPTOSY, and IDENTIY. These are among 3 currently registered trademarks in the portfolio.

What is Min Cui's trademark registration success rate?

Min Cui has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.